-
T352366-1g2-Tridecenoic Acid.
-
T352366-25g2-Tridecenoic Acid.
-
T352366-5g2-Tridecenoic Acid.
-
U303689-1g2-Undecenoic Acid.
-
U303689-25g2-Undecenoic Acid.
-
U303689-5g2-Undecenoic Acid.
-
V354817-5mg2-Valeryl-17β-estradiol 17-Valerate.
-
R354011-5mg20(R)-Hydroxy Prednisolone.
-
C353436-250μg20-COOH-LTB|4|is an ω-oxidized metabolite of leukotriene B|4|. Leukotrienes have been shown to be potent eicosanoid lipid mediators derived from phospholipase-released Arachidonic Acid . These compounds have been reported to be involved in
-
C353436-50μg20-COOH-LTB|4|is an ω-oxidized metabolite of leukotriene B|4|. Leukotrienes have been shown to be potent eicosanoid lipid mediators derived from phospholipase-released Arachidonic Acid . These compounds have been reported to be involved in
-
H351183-100μg20-hydroxy Prostaglandin E2 is the putative first intermediate in the metabolism by cytochrome P450 of PGE2 . A similar compound, 19(R)-Hydroxy-prostaglandin E2 , has been shown to act as a potent smooth muscle relaxant and a selective EP2 receptor
-
H351183-50μg20-hydroxy Prostaglandin E2 is the putative first intermediate in the metabolism by cytochrome P450 of PGE2 . A similar compound, 19(R)-Hydroxy-prostaglandin E2 , has been shown to act as a potent smooth muscle relaxant and a selective EP2 receptor